NN
Nanobac Pharmaceuticals, Incorporated
NNBP · OTC
$0.00 +0.00% (+$0.00)
Market Cap 21.5K €
P/E Ratio 0.00x
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
95 /100
Cheap P/E 0.00x
EV/EBITDA 2.00x
PEG 2.32x
Growth
9 /100
Declining Rev. growth 33.29%
Book val. growth 3.29%
EPS growth N/A
Profitability
82 /100
Strong Gross margin 45.07%
Net margin 9.35%
Op. margin 22.27%
Quality
60 /100
Average ROIC 11.66%
ROA 5.92%
Asset turnover 0.63x
Debt
41 /100
Moderate Debt/Equity 2.32x
Current ratio 1.12x
Net debt/EBITDA 2.00x
Stability
44 /100
Moderate Beta -8.83x
Rev. volatility 22.18%
Profitable years 1
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NNBP
Online
Sector
Healthcare
Industry
Biotechnology
CEO
John Stanton
Employees
1
Headquarters
Tampa